Member Info for neilrich3

No further products will be sold under any brands/trademarks acquired as part of the Omega Infectious Diseases acquisition in 2018, and as a result the remaining intangible asset has been fully written down in 2020.

https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/outcome-of-the-evaluation-of-rapid-diagnostic-assays-for-specific-sars-cov-2-antigens-lateral-flow-devices

One of the latest companies to have passed phase 3a LFT validation is BioPanda, they have an LFT for professional use only using saliva samples.
https://www.biopanda.co.uk/php/products/rapid/infectious_diseases/covid19saliva.php

Chrisdr2

Check out B2HS2L's post at 05:57

https://twitter.com/nph_group/status/1409882332522221572

NPH Group have expanded into a testing postal service and as previously stated are using Primerdesign.

Basically, the DHSC are claiming that the invoicing does not match the goods/services delivered/received?

https://www.theguardian.com/science/2021/jul/01/covid-perfect-storm-as-more-patients-hit-by-fungal-infections?CMP=Share_iOSApp_Other

Dr NIELSEN, Your best bet is to read the 2020 Annual Report, only released this week and available upon the Novacyt website.

This following sentence within the contract appears key, there's only an obligation to refund should NCYT be unable to replace the goods: Supplier’s maximum liability with any Authority claim under this warranty shall be to replace the faulty Goods
free of charge or refund to the Authority the full costs for such faulty Goods paid by the Authority to the Supplier if replacement is not possible.

Would be interesting to know how often both sides meet to discuss the dispute, what's the approximate timeframe for an ADR.

I think that the Directors shall be purchasing shares, however feel that they are prevented from doing so at present due to the DHSC dispute, lets face it, they know the price sensitive details of the dispute, they have all the information.

Sounds similar to what NCYT did with AZN, I think that we're ahead of the curve.

Chief Technical Officer, or Chief Technology Officer, is there a difference? Ajan is listed as the Chief Technology Officer within the Annual Report.

Some of the variation in reported sensitivity is explained by variation in the Ct value.62627 For example, a large evaluation of community testing in Liverpool (not included in the Cochrane Review) among people without symptoms found relatively high sensitivity when testing people with a lower Ct (>80% for samples requiring fewer than 20 PCR cycles to detect the virus—ie, Ct <20), but very low sensitivity at high Ct values (6% for a Ct value of 30-35).27 Taking a conservative threshold for an infectious sample (a Ct value =25) from the Liverpool study would suggest that LFDs have sensitivity of 67% for identifying a person who is infectious (95% confidence interval 41% to 87%).27
https://www.bmj.com/content/373/bmj.n1411

Some are suggesting that NCYT should have published a CT value, anyone that understands the significance please explain.

What a muppet, LFT have been around for decades.
https://twitter.com/EquityTrader888/status/1409781784955473921

Great news! Would have liked more info on the partnership, which I don't understand and confirmation of initial production capacity.

https://www.telegraph.co.uk/business/2021/06/28/hs2-forced-settle-spanish-train-maker-bungling-28bn-contract/

That's just one of many companies under his name.
https://find-and-update.company-information.service.gov.uk/company/10541091/filing-history

Lets face it, there's nothing in the main stream press/media and Celixir are still in business.
Better Science is Leonid Schneider's website. He was permanently banned from Twitter, as Twitter explained for “inciting other people to engage in the targeted harassment of”

Schneider was banned from Twitter for harassing scientists. Here, he antisemitically attacked a famous Jewish scientist, Ruggiero Moshe Santilli: